Evolent Health (9EH) Income Statement
Evolent Health Income Statement
Last quarter (Q2 2026), Evolent Health's total revenue was $652.52M, an increase of 46.86% from the same quarter last year. In Q2, Evolent Health's net income was $-28.36M. See Evolent Health’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.88B | $ 2.55B | $ 1.96B | $ 1.35B | $ 907.96M | |
| $ 284.03M | $ 367.35M | $ 460.47M | $ 316.58M | $ 250.41M | |
| $ 288.47M | $ 407.84M | $ 531.68M | $ 312.94M | $ 292.82M | |
| Depreciation and Amortization | $ 115.85M | $ 118.37M | $ 123.42M | $ 90.25M | $ 60.04M |
| $ -361.31M | $ 80.06M | $ -24.79M | $ 43.75M | $ 55.66M | |
| $ -4.43M | $ -40.48M | $ -71.21M | $ 3.64M | $ -42.41M | |
| $ -530.20M | $ -22.55M | $ -131.19M | $ -65.72M | $ 12.61M | |
| $ -534.64M | $ -63.04M | $ -202.41M | $ -62.08M | $ -29.80M | |
| $ -534.51M | $ -61.62M | $ -113.04M | $ -19.16M | $ -37.60M | |
| Per Share Metrics | |||||
| Basic EPS | $ -5.07 | $ -0.81 | $ -1.28 | $ -0.20 | $ -0.36 |
| Diluted EPS | $ -5.07 | $ -0.81 | $ -1.28 | $ -0.20 | $ -0.36 |
| Weighted Average Shares Outstanding | 114.21M | 114.68M | 111.25M | 93.70M | 86.07M |
| Weighted Average Shares Outstanding (Diluted) | 114.21M | 114.68M | 111.25M | 93.70M | 86.07M |
Currency in USD
